I know no matter what I say to you you will bash my answers but I will answer anyway. I also know that no other CEO of any public company takes the time to answer questions like this.
1) JC is a bad guy - we already knew this. Steve makes a deal with him, makes him President. Then tells us he was a bad guy anyway (like we didn't already know) and we are better off without him.
When we made the deal with JC we did not know about him not paying payroll taxes. We did not know the employees that later contacted us and told me he did not pay them. We did not know some day in the future he would lie about how many stations we where on. We bought the assets because we did not want to be held to any liabilities that there may have been, but that is a common way to buy operations and defend yourself against unforeseen issues.
2) Some affiliates have not been broadcasting for months. There are shareholders who apparently knew of this before Steve did. Not long ago, Steve says that he was recently made aware of these affiliates being off the air - months later. This is where "all our efforts" were focused but apparently not focused enough to know that there was dead air in major markets.
JC was the one in charge of affiliates. He was the person that communicated with them. He hid the communications he had with them. I didn't check his emails everyday or ever because thats not something you do. When we found out about a group of them being off the air we confronted JC and rather then respond he attacked and tried to push me out of the company so he could hide what we found. This did not work of course. As we where voting to fire him and sue him for the shares he and Punch received he demanded a recision under CA law. We signed the agreements to buy Punch and hire him under Florida law. So his recision demand held no effective power. The goal was to get rid of him and get all our shares back. One legal team required 70K and the other one 20k to do this. Rather then spend a min of 90k my lawyer recommend we just accept his recession request because it get us what we wanted.
3) A year ago the countdown that led to the major run led to the PR of the EZ-VIP deal. That was supposed to be the "next level." Just a reminder. That deal died. And this does not feel like a next level.
This was a TV which we where going to produce. Al Nelson could not deliver the stars he initially said he could so without the stars the show made no sense so we pulled the plug. At the time we did not own a TV network. It was exciting to move in the direction of producing a TV series and we eventually continued in that direction.
4) We had no revenues in a quarter where again "all efforts" were put toward TV. Yes, the deal was rescinded but what does "all efforts" exactly mean. Steve once said that the self-help site he had up (in the past) made a couple grand a month with him doing nothing. Yet, that also made no money. This doesn't make any sense.
Makes all the sense in the world. There are limited hours in the day. I have only a limited budget so I had to focus on what would make us the most money. That was television. When we had extra revenues we would add staff and begin cultivating other areas.
5) We have yet to hear anything "official" from the lawyers in terms of the meat and potatoes of what the deal is with the falling out of Punch. We have received piece-meal info from Steve but that ain't enough. That piece-meal info left out that that we had no revs from punch. I only bring this up because STEVE said we would be receiving an official word from it. And we have not gotten it.
You have heard from our filings. They are very clear. Read them.
6) I may be beating a dead horse with the lawyer thing above. But that points to something - a trend - that is more sinister. Steve does not stick to his word with regards to when he is going to do something. This has happened in the past with the failed countdown. When you say you are going to do something at a specific time and then DON'T, your credibility is sacrificed.
There are delays in business. I have done my best to keep the public in the loop in the past as we moved towards deals. This is uncommon for public companies but I felt it would be a good idea to try to keep people informed as we moved forward. I learned that I was wrong. Because with so many moving parts things change. Through we can internally handle to rapid changes we came upon building a new media company, unless we micro managed our communications it was impossible to communicate the changes in the middle of deals. As an example in retrospect I would not have told anyone about the EZ TV show until it was in production. Especially in the TV business show deals are made and killed on a daily basis. To get a show to air with all the moving parts is a combination of all the stars aligning and some luck. Currently we are many projects in the works but will not announce any of them till we begin filming.
I know no matter what I say to you you will bash my answers
Top 10 Most Recent News Articles
Webull Faces Class Action: Key Details for Investors
What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...
Continue Reading
Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance
Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...
Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results
Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...
Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion
Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...
Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026
Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...
Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices
Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...
Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart
A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...
Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West
Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...
Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years
A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...
Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa
Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...
Continue ReadingTop 5 Most Recently Viewed Articles
Exploring the Growth of the Sodium Bisulfite Market by 2034
Understanding the Growth of the Sodium Bisulfite Market The sodium bisulfite market is experiencing significant momentum as it progresses towards a bright future, with expectations of reaching USD 1,180.7 million by 2034, up from USD 750.3 million in 2024. This growth is driven by an increasing awareness of environmental issues and its versatile applications in various...
Continue Reading
Photocure ASA Reports Impressive Q2 Growth and Outlook
Photocure ASA Achieves Record Revenue in Q2 Photocure ASA has shared strong results for the second quarter of the year, showcasing remarkable growth in its Hexvix/Cysview product line. This quarter marked an unprecedented achievement with revenues reaching NOK 135.6 million, reflecting a significant increase compared to NOK 122.4 million from the same period last year....
Continue Reading
Ben & Jerry's Unveils New Flavor Inspired by Noah Kahan
Ben & Jerry's Launches Exclusive Flavor with Noah Kahan Ben & Jerry's, the iconic ice cream brand that loves to explore creative flavors, has just introduced an exciting new flavor called Northern Latte-tude. This one-of-a-kind creation is the result of a collaboration with musician Noah Kahan, with the goal of not only delighting fans but also supporting an important...
Continue Reading
Cisco Analyst Coverage Initiation Highlights: Stocks to Watch
Latest Analyst Ratings on Notable Stocks In a dynamic market environment, top analysts analyze and provide insights on various companies. Recently, several key analysts have shared significant ratings and price targets for notable stocks, including Cisco Systems, Inc. (NASDAQ: CSCO) and Shopify Inc. (NASDAQ: SHOP). Let's delve into what they have to say. Shopify Inc....
Continue Reading
Nike's Leadership Shakeup: A Bright Future Ahead for the Brand
Nike's Steady Outlook Amid Leadership Changes BMO Capital Markets has recently reaffirmed its Outperform rating for Nike Inc. (NYSE:NKE), setting a price target at $92.00 per share. This positive outlook follows the recent appointment of Elliott Hill as President and CEO, a change many investors have eagerly awaited. Hill's return is seen as a hopeful sign for the...
Continue Reading